TraceLink launches new Serialized Product Intelligence solution
Allows companies to proactively monitor their serialized operations and gain actionable insights to avoid costly delays and ensure product availability.
TraceLink, a digital platform company for the life science supply chain, has introduced Serialized Product Intelligence, a new cloud application that uses serialization data to provide actionable intelligence and drive operational excellence.
As more compliance mandates continue to emerge around the world, Serialized Product Intelligence simplifies the complexity of managing data across companies’ serialization operations. Now, companies can proactively monitor serialized operations, identify supply chain issues early, avoid costly delays and maintain timely product delivery to market.
Serialized Product Intelligence is a fully automated, self-service analytics application, built on TraceLink’s new Opus Digital Network Platform, the only digital network platform designed to support the development of multi-enterprise business applications for the pharmaceutical industry.
With this cloud application, companies can proactively aggregate and analyse serialization data to accelerate the resolution of supply chain disruptions and improve on-time delivery of medicines.
Serialized Product Intelligence provides companies with the first step to leverage data as a foundation for using more advanced technologies to predict and prevent critical business issues from occurring.
Companies can build on their serialization investment by unlocking the value of serialization data across their enterprise, gaining from the following benefits:
“Serialization will create enormous value for the entire supply chain, far beyond meeting regulatory requirements. As the crucial link to delivering actionable intelligence, companies can use serialization as the foundation for the digital transformation of their supply chain,” said Shabbir Dahod, president and CEO, TraceLink.
He added: “Current processes for managing serialization operations are unsustainable and riddled with complexities, with data coming from various sources and a growing number of new compliance mandates emerging across the globe. Serialized Product Intelligence eliminates these complexities, providing companies with a single source of the truth to identify and resolve disruptions quickly and keep operations on track to ensure medicines reach patients safely and on time.”
Related News
-
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc... -
News Key takeaways from Saudi Arabia's National Biotechnology Strategy
In January 2024, Saudi Arabia released its National Biotech Strategy, an ambitious plan to localise biomanufacturing, incentivise R&D and establish the Kingdom as the regional biotech leader by 2030, and an internationally recognised hub by 2040. -
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance